Working in partnership with Diagnostics Development based in Sweden, we can now offer access to biomarkers and antibodies that may compliment or enhance your current test portfolio. We are pleased to be part of this JV which will support our customer’s development pathway further.  We have already developed assays on our Agilis™ platform with a number of the biomarkers such as HNL and EDN.

To find out the full list please follow the link below that will take you to our partner website. Alternatively, please do get in touch directly by filling out our contact form below.